Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

ARTL Insider Trading (Artelo Biosciences)

Insider Ownership Percentage: 2.34%
Insider Buying (Last 12 Months): $9,775.00
Insider Selling (Last 12 Months): $0.00

Artelo Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Artelo Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Artelo Biosciences Share Price & Price History

Current Price: $0.85
Price Change: Price Increase of +0.04 (4.94%)
As of 09/17/2021 01:00 AM ET

This chart shows the closing price history over time for ARTL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

Artelo Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2021Gregory D. GorgasCEOBuy8,500$1.15$9,775.00270,676View SEC Filing Icon  
5/15/2020Gregory D. GorgasCEOBuy4,200$1.22$5,124.00
5/4/2020Connie MatsuiDirectorBuy41,667$1.27$52,917.09
5/4/2020Gregory D. GorgasCEOBuy4,167$1.27$5,292.09
11/4/2019Gregory D. GorgasCEOBuy2,400$2.05$4,920.00
11/1/2019Gregory D. GorgasCEOBuy7,600$2.18$16,568.00
10/15/2019Gregory D. GorgasCEOBuy2,600$2.45$6,370.00
10/11/2019Gregory D. GorgasCEOBuy2,700$1.96$5,292.00
See Full Table
Insider Buying at Artelo Biosciences?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Artelo Biosciences and related companies.

SEC Filings (Institutional Ownership Changes) for Artelo Biosciences (NASDAQ:ARTL)

11.85% of Artelo Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARTL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Artelo Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/17/2021Virtu Financial LLC22,594$27K0.0%-85.3%0.092%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC74,170$88K0.0%-59.0%0.303%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC556,738$0.66M0.0%N/A2.273%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.862,172$1.03M0.0%+247.5%3.520%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC28,427$27K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp86,603$0.10M0.0%-15.4%0.354%Search for SEC Filing on Google Icon
8/6/2021HighTower Advisors LLC62,000$74K0.0%N/A0.253%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC153,769$0.25M0.0%N/A0.664%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC180,814$0.30M0.0%N/A0.781%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC21,108$34K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP200,000$0.33M0.0%-20.0%0.864%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp102,390$0.17M0.0%N/A0.442%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC141,273$0.23M0.0%+132.1%0.610%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG15,675$26K0.0%N/A0.068%Search for SEC Filing on Google Icon
4/6/2021LVM Capital Management Ltd. MI20,000$33K0.0%N/A0.127%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Artelo Biosciences logo
Artelo Biosciences, Inc. is a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.
Read More on Artelo Biosciences

Today's Range

Now: $0.85
Low: $0.82
High: $0.86

50 Day Range

MA: $0.94
Low: $0.80
High: $1.10

52 Week Range

Now: $0.85
Low: $0.45
High: $3.67

Volume

333,627 shs

Average Volume

3,586,475 shs

Market Capitalization

$20.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.26

Who are the company insiders with the largest holdings of Artelo Biosciences?

Artelo Biosciences' top insider shareholders include:
  1. Gregory D Gorgas (CEO)
  2. Connie Matsui (Director)

Who are the major institutional investors of Artelo Biosciences?

Artelo Biosciences' top institutional investors include:
  1. Vanguard Group Inc. — 3.52%
  2. Renaissance Technologies LLC — 2.27%
  3. Bank of New York Mellon Corp — 0.35%
  4. Citadel Advisors LLC — 0.30%
  5. HighTower Advisors LLC — 0.25%
  6. Penserra Capital Management LLC — 0.12%

Which major investors are selling Artelo Biosciences stock?

Within the previous quarter, ARTL stock was sold by these institutional investors:
  1. Virtu Financial LLC
  2. Citadel Advisors LLC
  3. Bank of New York Mellon Corp

Which major investors are buying Artelo Biosciences stock?

Within the previous quarter, ARTL stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Renaissance Technologies LLC
  3. HighTower Advisors LLC
  4. Penserra Capital Management LLC
Within the last year, these company insiders have bought Artelo Biosciences stock:
  1. Gregory D Gorgas (CEO)
  2. Connie Matsui (Director)
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel